Press Releases Archives - Cleveland HeartLab, Inc.

Quest Diagnostics to accelerate cardiovascular disease biomarker discovery as part of One Brave Idea™ initiative to end coronary heart disease

Cleveland Heartlab — Wed, 14 Nov 2018 02:25:09 +0000

The power of healthcare data gives rise to novel markers of cardiovascular disease and stroke in the earliest, preventable stages CHICAGO, Nov.11, 2018 — Developing novel approaches to understand cardiovascular health and pre-disease is the cornerstone strategy of One Brave Idea™, a research initiative led by Dr. Calum MacRae, vice chair for Scientific Innovation in the department of Medicine at Brigham ...

The post Quest Diagnostics to accelerate cardiovascular disease biomarker discovery as part of One Brave Idea™ initiative to end coronary heart disease appeared first on Cleveland HeartLab, Inc..

Cleveland HeartLab and Quest Diagnostics Forming Base for Quest’s National Cardiometabolic Center of Excellence

Cleveland Heartlab — Wed, 18 Oct 2017 20:43:33 +0000

– Cleveland HeartLab to be the base for Quest’s first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease – Relationship to establish a strategic collaboration to identify and offer diagnostic services from Cleveland Clinic’s innovations in inflammation and other areas of medicine SECAUCUS, N.J. and ...

The post Cleveland HeartLab and Quest Diagnostics Forming Base for Quest’s National Cardiometabolic Center of Excellence appeared first on Cleveland HeartLab, Inc..

Cleveland HeartLab Launches Only Clinical Test for Measuring TMAO, an Important Measure of Gut Dysfunction that is Associated with Cardiovascular Disease Risk

Cleveland Heartlab — Tue, 16 Feb 2016 12:29:26 +0000

Download Press Release Innovative new test published in The New England Journal of Medicine detects levels of TMAO – which, when elevated, correlates with a two-fold increased risk of heart attack or stroke February 16, 2016, CLEVELAND: Cleveland HeartLab Inc., the premier cardiovascular disease management company, announced it has successfully developed, validated and launched a new clinical test for the assessment of ...

The post Cleveland HeartLab Launches Only Clinical Test for Measuring TMAO, an Important Measure of Gut Dysfunction that is Associated with Cardiovascular Disease Risk appeared first on Cleveland HeartLab, Inc..

Cleveland HeartLab Partnering with Procter & Gamble and Cleveland Clinic to Advance Discovery in Heart Disease with TMAO Testing

Cleveland Heartlab — Wed, 19 Aug 2015 12:33:35 +0000

Link to Press Release Corporate Communications 9500 Euclid Ave. / JJN4-01 Cleveland, OH 44195 Phone: 216.444.0141 Fax: 216.445.3040 clevelandclinic.org/newsroom Contacts: Cleveland Clinic: Robert Smith, 216.385.6179, smithr5@ccf.org P&G: Michelle Vaeth, 513-622-4727, vaeth.m@pg.com Cleveland HeartLab: Bethany Hilt, 330-338-6633, bethany.hilt@gmail.com CLEVELAND CLINIC PARTNERING WITH PROCTER & GAMBLE AND CLEVELAND HEARTLAB TO ADVANCE DISCOVERY IN HEART DISEASE The Partners Will Build Upon ...

The post Cleveland HeartLab Partnering with Procter & Gamble and Cleveland Clinic to Advance Discovery in Heart Disease with TMAO Testing appeared first on Cleveland HeartLab, Inc..

Journal of Medical Economics – CHL testing could reduce events by 10%, saving $187 Million

Cleveland Heartlab — Tue, 21 Apr 2015 14:29:27 +0000

Link to Press Release New Study Shows Cleveland HeartLab Inflammation Testing can Prevent Thousands of Heart Attacks and Strokes, Averting $187 Million in Healthcare Costs for Cardiovascular Disease—The Number One Killer of Men and Women in the U.S The American Heart Association estimates 50 percent of all heart attacks and strokes occur in individuals with normal cholesterol. Cleveland HeartLab’s inflammation ...

The post Journal of Medical Economics – CHL testing could reduce events by 10%, saving $187 Million appeared first on Cleveland HeartLab, Inc..

Nutrasource Diagnostics Inc. Announces the Availability of the OmegaCheck™ Omega-3 Blood Test through Cleveland HeartLab

Cleveland Heartlab — Fri, 13 Mar 2015 17:44:58 +0000

Link to PRWeb Press Release Guelph, Ontario, Canada (February 23, 2015) Nutrasource Diagnostics Inc. (NDI) is pleased to announce its recent collaboration with Cleveland HeartLab (CHL) for the development of the OmegaCheck™ diagnostic blood test for the quantification of omega fatty acids. As a global leader in launching proprietary tests to more accurately assess cardiovascular disease risk, CHL developed and ...

The post Nutrasource Diagnostics Inc. Announces the Availability of the OmegaCheck™ Omega-3 Blood Test through Cleveland HeartLab appeared first on Cleveland HeartLab, Inc..

CHL Launches New Medical Education Program

Cleveland Heartlab — Mon, 09 Mar 2015 19:07:54 +0000

Link to PRWeb Press Release World-class, accredited continuing medical education (CME) now available as one-stop source for information on the identification and prevention of metabolic and cardiovascular disease CLEVELAND, March 9, 2015 – Cleveland HeartLab (CHL), the premier cardiovascular management company, announces the launch of its new CME Web Portal, Continuing Education from Cleveland HeartLab. The website (www.chlcme.com ) will ...

The post CHL Launches New Medical Education Program appeared first on Cleveland HeartLab, Inc..

Cleveland HeartLab Tests can save $180 Million in Healthcare Costs, As discussed on Yahoo Health:

Cleveland Heartlab — Mon, 02 Jun 2014 15:35:15 +0000

Cleveland HeartLab Presents Research Demonstrating its Prognostic Tests can save $180 Million in Healthcare costs related to Cardiovascular Disease, the Number One killer of Men and Women in the US Read the Story on Yahoo Health: http://health.yahoo.net/experts/dayinhealth/simple-tests-heart-attack-risk-could-save-lives-and-180-million First-of-its-kind economic model to be presented today at the International Society of PharmacoEconomics and Outcomes Research (ISPOR) conference validates enormous cost savings from ...

The post Cleveland HeartLab Tests can save $180 Million in Healthcare Costs, As discussed on Yahoo Health: appeared first on Cleveland HeartLab, Inc..

Clinical Experts and Entrepreneurs to Converge on Cleveland to Discuss Broad-Based Strategies for Reducing Chronic Disease

Cleveland Heartlab — Tue, 25 Feb 2014 14:16:29 +0000

Cleveland HeartLab announces highlight speakers for its Fifth Annual Symposium, “Where Inflammation Meets Lipids®: Broad-Based Strategies for Chronic Disease Prevention.” CLEVELAND, February 25, 2014 – Cleveland HeartLab Inc., a rapidly growing specialty clinical laboratory and cardiovascular disease management company, today announced that its Fifth Annual Symposium titled, “Where Inflammation Meets Lipids®: Broad-Based Strategies for Chronic Disease Prevention,” will focus on ...

The post Clinical Experts and Entrepreneurs to Converge on Cleveland to Discuss Broad-Based Strategies for Reducing Chronic Disease appeared first on Cleveland HeartLab, Inc..

Inflammation Testing Proving Valuable Predictor of Cardiac Risk for Corporate Wellness Programs

Cleveland Heartlab — Wed, 05 Feb 2014 21:45:56 +0000

Cleveland HeartLab CEO to present findings at Health & Wellness Congress CLEVELAND, OH (Feb. 5, 2014) – Leading companies are increasingly recognizing that traditional fingerstick screening for glucose and lipids is proving inadequate when identifying near-term cardiovascular risk in employed populations, according to Jake Orville, CEO of Cleveland HeartLab (CHL). This position is supported by data from the American Heart ...

The post Inflammation Testing Proving Valuable Predictor of Cardiac Risk for Corporate Wellness Programs appeared first on Cleveland HeartLab, Inc..